semaglutide en españa Qué diferencia hay entre Ozempic y Wegovy, el último fármaco contra la obesidad que llega a España? Valencia España 10 04 2025

GLP-1 receptor agonists are reasonable alternatives to SGLT-2 inhibitors in patients with similar risk profiles because this drug class also improves mortality, although to a lesser extent

When follicles spend too much time resting and not enough time actively growing, hair gets thinner and falls out faster than it grows back

A clinician may discuss a GLP-1 medicine because of diabetes or obesity, while also observing whether HS improves

Building upon our previous work using proteolytically activated hydrogels [1419], we envision using fusion proteins to release therapeutic proteins in response to disease-specific proteases